SUBSTIPHARM is a Pharmaceutical company company operating in the pharmaceutical industry.
Substipharm is a privately held pharmaceutical group, developing, supplying and commercializing pharmaceutical products in more than 80 products worldwide. Product pipeline includes more than 60 ongoing projects. Our focus is on niche or differentiating products (based on technology and market size), that we either market ourselves or that we license out to other pharmaceutical companies depending on countries. We have a successful portfolio of pharmaceutical products and dossiers including: .Pharmaceutical generics .
Company type
Pharmaceutical company
Products and services
Pharmaceutical Products / ATC coding, Custom Manufacturing, Finished Dosage Forms, Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with SUBSTIPHARM on LinkedIn
Address
SUBSTIPHARM, 24 Rue Erlanger, Paris, France, 75016
Stay ahead of trends and best practices
